Detalles de la búsqueda
1.
Efficacy of preexposure prophylaxis with monoclonal-antibody tixagevimab-cilgavimab against emerging SARS-CoV-2 resistant variants in patients with chronic lymphocytic leukemia.
Acta Haematol
; 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38471491
2.
COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022.
Euro Surveill
; 27(30)2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35904058
3.
Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022-2023 Winter Season.
Vaccines (Basel)
; 11(10)2023 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37897026
4.
Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up.
Clin Microbiol Infect
; 29(7): 918-923, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36921715
Resultados
1 -
4
de 4
1
Próxima >
>>